Tagged with Algeria,

Algeria Head of the Algerian National Laboratory for the Control of Pharmaceutical Products (LNCPP), an institution he helped found in 1995, Abdelaziz Gharbi describes the LNCPP’s journey, his great motivation to see international collaboration grow, and the role that Algeria can play in a context of regional influence. Last year saw…

Algeria Loic Galmard discusses the opportunities and challenges of setting up local production in Algeria, and the best strategies to increase market access and create a dialogue with the regulatory authorities. What are your first impressions of the local market in the 10 months that you have been here so far?…

Algeria Amine Sekhri, country manager for Roche Algeria discusses the potential for personalized precision medicine in Algeria and Roche’s important position within the Algerian market Could you please start by introducing yourself to our readers? This is actually my first role as a country manager. I am a physician, started my…

Algeria Professor Kamel Bouzid, president of the Algerian Society of Medical Oncology, provides an insight into the efforts to fight against cancer in Algeria. Could you please give us an overview of the cancer prevalence in Algeria? In Algeria, 75 percent of cancers are metastasized cancers, and only 25 percent are…

Algeria Reda El Baki, president of the French-Algerian Chamber of Commerce and Industry (CCIAF), wishes to build on the link that for long has united France and Algeria. He underlines recent improvements in regulation and expresses his hope that more French SMEs will come south of the Mediterranean, while also highlighting…

Algeria Prof. Messaoud Zitouni, head of the Algerian National Cancer Plan, highlights the Plan’s main advancements since 2015 as well as the gaps to still address. Three years after the launch of the Cancer Plan, what is the current status on achievements? Initially laid out as a five-year plan, two now…

Algeria A confluence of factors – urbanisation, industrialisation, poor eating habits and a sedentary lifestyle – have triggered a surge in noncommunicable diseases (NCDs) in Algeria. NCDs now account for 76 percent of all deaths in the North African nation. Cardiovascular diseases are the leading individual cause of death in Algeria,…

Algeria Sofiane Achi of El Kendi, one of Algeria’s leading pharma manufacturers, discusses the fresh ideas he has brought back to the company following a stint at Boehringer Ingelheim, manufacturing upgrades, and the country’s readiness for biosimilars. You decided to return to a company that you already know very well. How…

Algeria Dr. Zoubir Harrat heads the Institut Pasteur d’Algérie (IPA), after having spent most of his career with the institution. He talks of the importance to prepare for the healthcare challenges of the future, and how the only way to achieve this is through collaboration and training of future generations.  …

Algeria Long considered maladies of affluent urban populations in mature Western economies, non communicable diseases (NCDs)– such as diabetes, cancer, chronic respiratory and cardiovascular diseases – have been spreading silently and unchecked throughout the African continent to the point where they are now reaching epidemic proportions and becoming a major determinant…

Algeria In June 2017, PharmaBoardroom hosted an exclusive round table discussion with key players in Algerian healthcare on the role of health economics and patient data in health policy decision making. The participants were Dr Djaouad Brahim Bourkaib, Director General of Social Security in the Ministry of Labor, Jean-Paul Digy, Vice President for…

Algeria This chart shows how Algeria’s pharmaceuticals and healthcare system has evolved over time; from the creation of the Algerian Central Pharmacy (PCA) back in 1962, all the way to the implementation of the ANPP in 2017. Click here to download the latest roundtable discussion on Algerian healthcare